RESTASIS
ABBVIE CORPORATION
Quick answers
Is there a shortage of RESTASIS in Canada?
No. There is no current shortage of RESTASIS 0.05% reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
SANDIMMUNE ORAL SOL 100MG/ML
SANDOZ CANADA INC
SANDIMMUNE SOFT GELATIN CAP 100MG
SANDOZ CANADA INC
SANDIMMUNE I.V.
NOVARTIS PHARMACEUTICALS CANADA INC
NEORAL
NOVARTIS PHARMACEUTICALS CANADA INC
SANDIMMUNE SOFT GELATINE CAP 25MG
SANDOZ CANADA INC
SANDIMMUNE CAP 50MG
SANDOZ CANADA INC
DIN
02355655
Strength
0.05%
Dosage Form
Emulsion
Route
Ophthalmic
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from ABBVIE CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
35MG · DIN 02246896
150MG · DIN 02316838
35MG · DIN 02370417
0.5% · DIN 01968300
0.4% · DIN 02248722
0.45% · DIN 02369362
0.2% · DIN 02236876
0.15% · DIN 02248151
10MG · DIN 02443910
50UNIT · DIN 02531577
100UNIT · DIN 01981501
200UNIT · DIN 02531585